Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: nausea, vomiting, inability to tolerate pos major surgical or invasive procedure: mechanical intubation nephrostomy tube placement history of present illness: ========================================================= oncology moonlighter pgy-3 admission note , f age: 44 sex: f date of admission: ========================================================= . pcp: , oncologist: dr. () . cc: nausea, vomiting, inability to tolerate pos . hpi: 44 yo f with metastatic lung cancer to brain s/p recent chemotherapy (c2d1 of taxotere on ) who was transferred from oncology clinic with persistent nausea, vomiting, and hypotension to the 80s. patient of note recently had a ct torso from which showed progression of her metastatic disease including in her lungs, mediastinal lymph nodes, and new hepatic masses. she also had a follow-up mri brain which shows 4 new brain metastases. there has been discussion with her outpatient oncologist about clinical trials with tkis but the patient needs to off chemotherapy for one month and needs to qualify for the study. she has stable swelling in the rue and lue swelling, and continues on lovenox. seen by dr. in neuro clinic. she continues with daily vna pleurex drainage bilaterally was performed today, 600cc from r catheter and, 250 cc from the left catheter. . patient reports persistent nausea and vomiting for the several days. she did not have any nausea immmediately after her chemotherapy. she has been vomiting up her food, but no blood. no diarrhea, and no abdominal pain. no headache. she was finally able to keep some food down today. she received 1 l of ns in her clinic for an sbp of 80, decadron, zofran, and iv morphine for her back pain in the clinic prior to transfer to the ed. states her upper extremity swelling is worse after receiving ivfs today. . in ed vs were 99.1 103 97/65 20 96% 2l nc. lab sig for na of 128, cre of 1.7 (baseline 1.0), wbc of 22.3 and hct of 26.3. received ativan 2 mg iv x1 and 1 l ns in the ed. vs prior to transfer were: 97.3 98 117/70 18 100% on ra. . review of systems: (+) per hpi (-) denies fever, chills. denies headache, sinus tenderness, rhinorrhea or congestion. denied chest pain or tightness, palpitations. denied diarrhea, constipation or abdominal pain. no recent change in bowel or bladder habits. no dysuria. past medical history: past oncologic history: was in her usual state of health up until when she developed ruq abdominal pain. she was sent to the ed by her pcp. that time she had a normocytic anemia 32.5, ast 74, alt 148, t bili 0.2, ap 97, lipase 32. an abdominal us showed abnormal thickening of the gallbladder and cholecystitis, w/o intra/extra hepatic dilatation, changes c/w fatty liver disease, and a small pleural effusion. she underwent cholecystectomy and 1 week post op developed pericardial effusion. patient underwent pericardiocentisis (effusion was primarily rbcs, few wbcs, and culture negative, including afp per report). she underwent work up with tsh elevated to 5.6, with normal free t4 0.72, negative , negative rapid strep. she had a mammogram that showed benign microcalcifications, no radiographic evidence of malignancy. a repeat echocardiogram showed ef 60%, nl lv thickness and wall motion, normal rv/la, no valvular dysfunction and no effusion. . 1 week prior her admission, patient developed swelling in her right neck which was thought to be reactive lymphadenopathy. she also complains of cough. over the next two days she developed doe and went to where she was found to have redeveloped pericardial effusion w/o tamponade. she was therefore sent to for additional . cytology from pericardiocentesis revealed adenocarcinoma, positive for ck-7, ck-20, ttf-1, negative for gcdfp 15 and mammoglobin. also had multiple clots in both ues with multiple subsegmental pe's; received ivf filter and enoxaparin. hospital course was complicated by a large abdomino/pelvic hemoperitoneum due to ruptured ovarian cyst vs. drop metastases. ivc filter was placed. mri head showed solitary met in left temporal lobe which she underwent srs for on with dr. . - : c1d1 cisplatin/navelbine - c2d1 - c3d1 : continued slight interval improvement of disease. completed six cycles of cis/navelbine (c6d8 on ) chemotherapy complicated with hospital admission for neutropenia also concern for tuberculosis initially but seen by id, tuberculosis treatment not necessary based on subtype - admitted to with increase in dyspnea, facial swelling. pericardial tamponade requiring window and left pleural effusion. received chemo in hospital. extensive clot burden resulting in svc syndrome, no intervention possible. continued on lovenox : taxotere #1 (in hospital) - readmitted with right pleural effusion, pleurex placed. : port placed. : neuro follow-up mri with new brain mets. srs planned. : taxotere #2 . pmh: - lung adenocarcinoma with known mets to brain, dx ; metastatic to brain s/p cyberknife therapy, malignant pleural and pericardial effusions s/p pericardiocentesis (see above for further details) - dvts s/p ivc and svc filters - malignant pleural effusion s/p drainage - pe s/p ivf on chronic lovenox and s/p ivc filter - mycobacterium gordonae - s/p ccy - s/p pericardiocentesis social history: she is originally from the in , lives with husband. married. worked at . husband works in shipping warehouse. no smoking, alcohol, or illicit drug use family history: mother with diabetes. no family hx of cancer. physical exam: vs: 98.6 114/78 63 18 96% on 3 l nc ga: pleasant f aox3, nad heent: perrla. mm slightly dry. no lad. no jvd. neck supple. cards: pmi palpable at 5/6th ic space. no rvh. rrr s1/s2 heard. no murmurs/gallops/rubs. pulm: crackles at r/l lower bases bl. 2 pleurex catheters in place bandages c/d/i bl. abd: soft, nt, +bs. no g/rt. neg hsm. neg sign. extremities: wwp, no edema in blles, 4+ pitting edema in bilateral upper extremities. pertinent results: 02:15pm blood wbc-22.3* rbc-2.68* hgb-9.0* hct-26.3* mcv-98 mch-33.5* mchc-34.2 rdw-18.3* plt ct-353 02:15pm blood neuts-97.3* lymphs-1.8* monos-0.7* eos-0.1 baso-0.1 02:15pm blood plt ct-353 02:15pm blood pt-13.1 ptt-41.5* inr(pt)-1.1 02:15pm blood glucose-139* urean-18 creat-1.7* na-128* k-4.1 cl-93* hmicrobiology: blood culture () - pending . imaging: : ct torso w/o contrast: impression: 1. interval increase in the degree of bulky supraclavicular, axillary, and mediastinal lymphadenopathy. 2. attenuation of the right brachiocephalic/subclavian and left brachiocephalic veins not as well evaluated on this study due to contrast timing. 3. heterogeneous enhancement of the thyroid, new from the prior study, concerning for infarction or hypoperfusion. metastatic infiltration is another less likely consideration. 4. improved aeration of the lungs despite right upper lobe bronchial obstruction. right upper and middle lobe masses appear enlarged compared with the ct torso with bilateral chest tubes in place and small left pleural effusion. 5. multiple new hepatic metastases as described above with new right and left adrenal lesions and possible development of peritoneal disease. 6. diffuse osseous involvement of multiple lower cervical and upper thoracic vertebral bodies as well as focal lesions in the l2 and l3 vertebral bodies. irregularity of the t3 and t4 superior endplates concerning for new pathologic fractures. . co3-25 angap-14 brief hospital course: a/p: 44 yo woman with metastatic lung cancer s/p six cycles of cisplatin and navelbine presenting with persistent nausea, vomiting, and hypotension presented from oncology clinic found to have obstructive uropathy and pyelonephritis. # obstructive uropathy: the patient underwent nephrostomy tube placement by interventional radiology in attempt to alleviate obstruction likely caused by metastatic spread of primary lung cancer to the retroperitoneum. procedure complicated by hypotension and septic shock likely related to urosepsis. the patient required mechanical intubation, multiple antibiotics and pressor support to maintain adequate bps. the patient's family decided to withdraw care after improvement seemed unlikely. the patient's family was at her bedside at the time of death. . #) nsclc adeno, stage iv: advanced disease - per primary oncologogist the patient had worsening lymphadenopathy, liver, brain and bony mets since most recent course of taxotere. . #) h/o pe: ivc filters inplace. continued anticoagulation, held for procedure . #) stage 2 ulcer - stable medications on admission: . oxygen please provide 2-4l oxygen by nasal cannula when ambulating prn 2. dexamethasone 2 mg tablet sig: one (1) tablet po daily (daily). 3. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 5. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po every four (4) hours as needed for pain. 6. benzonatate 100 mg capsule sig: one (1) capsule po tid (3 times a day). 7. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 8. ipratropium bromide 17 mcg/actuation hfa aerosol inhaler sig: two (2) puffs inhalation every six (6) hours. 9. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 10. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed for constipation. 11. codeine-guaifenesin 10-100 mg/5 ml syrup sig: 5-10 mls po q6h (every 6 hours) as needed for cough. 12. enoxaparin 60 mg/0.6 ml syringe sig: one (1) injection subcutaneous q12h (every 12 hours). 13. morphine 15 mg tablet sig: one (1) tablet po every twenty-four(24) hours as needed for pain: to be used for pain from pleurex drainages; do not drive or operate machinery. . discharge medications: na discharge disposition: expired discharge diagnosis: obstructive uropathy sepsis metastatic lung cancer discharge condition: expired discharge instructions: na followup instructions: na md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours percutaneous nephrostomy without fragmentation diagnoses: acidosis anemia, unspecified malignant neoplasm of liver, secondary acute kidney failure, unspecified unspecified septicemia hyposmolality and/or hyponatremia severe sepsis nausea with vomiting acute respiratory failure secondary malignant neoplasm of brain and spinal cord malignant neoplasm of upper lobe, bronchus or lung septic shock antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use encounter for palliative care hydronephrosis secondary and unspecified malignant neoplasm of intrathoracic lymph nodes other specified diseases of pericardium disorders of magnesium metabolism secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of retroperitoneum and peritoneum edema other ureteric obstruction malignant pleural effusion 

Answer: The patient is high likely exposed to